Machine Learning-Driven Prediction of Antigenic Drift in Hemagglutinin for Seasonal Influenza Surveillance

Introduction

Influenza A viruses (IAV) circulate in a wide range of avian and mammalian hosts, causing significant morbidity and mortality in poultry, swine, equine, and companion animal populations [1, 2]. The hemagglutinin (HA) glycoprotein is the primary target of host neutralizing antibodies and undergoes continuous antigenic evolution through the accumulation of amino acid substitutions in its globular head domain [3]. This process, termed antigenic drift, enables viral escape from pre-existing immunity and necessitates frequent updates of veterinary influenza vaccines [4]. Accurate prediction of antigenic drift is therefore a central goal of seasonal influenza surveillance programs in both human and animal health sectors [5].

Machine learning (ML) and deep learning (DL) methods have emerged as powerful tools for modeling the complex sequence-structure-function relationships that govern HA antigenic evolution [6]. By integrating large-scale sequence data, structural information from X-ray crystallography and cryo-electron microscopy, and functional measurements from deep mutational scanning (DMS) experiments, these computational approaches can forecast which HA mutations are most likely to confer immune escape [7]. This article provides a detailed technical review of the biological mechanisms underlying antigenic drift, the computational frameworks used to predict it, and the practical applications of these predictions for veterinary influenza surveillance and vaccine strain selection.

Structural Virology of Hemagglutinin

The HA trimer is a class I viral fusion protein composed of two disulfide-linked subunits: HA1 (globular head) and HA2 (stalk) [8]. The receptor-binding site (RBS) resides in the membrane-distal HA1 domain and mediates attachment to sialic acid-containing receptors on host cells [9]. Five major antigenic sites have been mapped on the HA1 surface of H3 subtype viruses (sites A through E), each comprising multiple overlapping epitopes recognized by neutralizing antibodies [10]. In avian IAV, antigenic sites are similarly distributed but vary in exact location and composition across subtypes [11].

Antigenic drift occurs primarily through point mutations in these epitopic regions that reduce antibody binding affinity without compromising receptor-binding or fusion functions [12]. The biophysical basis of escape involves steric hindrance, electrostatic repulsion, or loss of hydrogen bond contacts between the antibody paratope and the HA epitope [13]. Some mutations also alter local backbone conformation or glycan shielding, further masking conserved epitopes [14]. The HA stalk domain, while more conserved, can also accumulate escape mutations under sustained antibody pressure, though at a lower rate than the head domain [15].

Antigenic Drift Mechanisms

Antigenic drift is driven by the error-prone RNA-dependent RNA polymerase of IAV, which generates a high mutation rate of approximately 10^-3 to 10^-5 substitutions per nucleotide per replication cycle [16]. In vaccinated or previously infected populations, antibodies exert strong selective pressure favoring variants with altered epitopes [17]. The resulting amino acid substitutions are not random; they cluster in solvent-exposed loops and beta-sheets of the HA1 domain that are accessible to antibodies [18].

The concept of antigenic distance, often quantified using hemagglutination inhibition (HI) assay titers, provides a phenotypic measure of drift [19]. Computational models aim to predict these distances from HA sequences alone, enabling rapid assessment of emerging variants [20]. Key challenges include the high dimensionality of sequence space, epistatic interactions between mutations, and the context-dependence of escape phenotypes on host species and prior immune history [21].

Machine Learning Approaches

Sequence-Based Models

Early ML approaches for antigenic drift prediction used random forests and support vector machines trained on HA1 amino acid sequences to classify strains into antigenic clusters [22]. Features included position-specific substitution scores, physicochemical properties of residues, and phylogenetic distances [23]. More recent methods employ deep neural networks with attention mechanisms that learn to weight the importance of individual residues for antigenic phenotype [24].

Convolutional neural networks (CNNs) applied to one-hot encoded sequences can capture local motif patterns associated with escape [25]. Recurrent neural networks (LSTMs) model the sequential dependencies along the HA sequence, though their utility is limited by the lack of long-range positional ordering in protein sequences [26]. Transformer-based protein language models, such as those pre-trained on large sequence databases, have shown superior performance in predicting antigenic drift by learning distributed representations of amino acid contexts [27].

Structure-Based Models

Incorporating three-dimensional structural information improves prediction accuracy by explicitly modeling the spatial arrangement of epitopes [28]. Features derived from HA crystal structures include solvent accessibility, residue depth, B-factor (thermal mobility), and contact maps with known antibody structures [29]. Graph neural networks (GNNs) represent the HA trimer as a graph where nodes are residues and edges encode spatial proximity, allowing the model to propagate information across the protein surface [30].

Molecular dynamics (MD) simulations provide dynamic ensembles that capture conformational flexibility of epitopes, which can affect antibody recognition [31]. ML models trained on MD-derived features, such as root-mean-square fluctuation (RMSF) and principal component analysis of backbone motions, can identify residues whose conformational sampling correlates with escape potential [32]. Homology modeling and AlphaFold-predicted structures enable structure-based predictions for subtypes lacking experimental coordinates [33].

Deep Mutational Scanning and Fitness Landscapes

DMS experiments systematically measure the effect of every single amino acid mutation in the HA1 domain on antibody binding or viral fitness [34]. These data are used to train supervised ML models that predict escape scores for unseen mutations or combinations [35]. Fitness landscapes constructed from DMS data reveal that most escape mutations incur a fitness cost, often through reduced receptor binding or decreased thermostability, which must be compensated by secondary mutations [36].

Generative models, including variational autoencoders and generative adversarial networks, can propose novel HA sequences that are predicted to escape existing immunity while maintaining fitness [37]. These in silico designed variants can then be synthesized and tested experimentally, accelerating the identification of potential future drift variants [38].

Workflow Overview

The following Mermaid diagram summarizes a typical ML-driven antigenic drift prediction pipeline:

flowchart TD
    A[Sequence Databases<br>GISAID, GenBank], > B[Sequence Alignment<br>and Phylogeny]
    B, > C[Feature Engineering<br>Sequence + Structure]
    C, > D[ML Model Training<br>CNN, GNN, Transformer]
    D, > E[Prediction of<br>Antigenic Distance]
    E, > F[Vaccine Strain<br>Selection]
    B, > G[Deep Mutational<br>Scanning Data]
    G, > D
    H[Experimental<br>HI Titers], > E
    I[Structural Models<br>X-ray, Cryo-EM, AlphaFold], > C

Data Sources and Surveillance

The Global Initiative on Sharing All Influenza Data (GISAID) is the primary repository for influenza HA sequences from both human and animal sources [39]. Veterinary surveillance programs, such as those coordinated by the World Organisation for Animal Health (WOAH) and national reference laboratories, contribute thousands of avian and swine IAV sequences annually [40]. These data are often accompanied by metadata including host species, geographic origin, and subtype.

HI assay data from routine antigenic characterization are used as ground truth labels for ML models [41]. However, HI data are sparse and subject to inter-laboratory variability, motivating the development of sequence-only prediction methods [42]. DMS datasets, while limited to a few reference strains, provide high-resolution functional maps that can be generalized across subtypes using transfer learning [43].

Practical Applications

Vaccine Strain Selection

In poultry and swine, influenza vaccines are typically inactivated whole-virus preparations that must be updated periodically to match circulating strains [44]. ML models that predict antigenic drift can guide the selection of vaccine seed strains by identifying variants that are antigenically representative of the current season's predominant clades [45]. For example, a model trained on historical H3N2 swine IAV data can forecast which HA mutations will lead to a significant drop in cross-reactivity with existing vaccine strains [46].

Pandemic Preparedness

Zoonotic IAV subtypes, such as H5N1 and H9N2, pose pandemic threats to both animal and human populations [47]. ML-driven drift prediction can identify mutations in avian HA that increase antigenic novelty relative to pre-existing vaccine strains, signaling the need for preemptive vaccine updates [48]. Integration with receptor-binding prediction models, as discussed in Machine Learning-Driven Prediction of Receptor-Binding Dynamics in Emerging Zoonotic Coronaviruses, allows simultaneous assessment of antigenic and receptor-binding changes [49].

Surveillance Prioritization

Computational predictions can prioritize field isolates for experimental antigenic characterization, reducing laboratory workload and costs [50]. Models that output uncertainty estimates (e.g., Bayesian neural networks) can flag strains with high prediction variance for confirmatory testing [51].

Challenges and Future Directions

Several limitations remain. First, ML models trained on historical data may fail to predict entirely novel antigenic configurations that arise through recombination or reassortment [52]. Second, the lack of standardized antigenic data across veterinary species hampers model generalization [53]. Third, epistatic interactions between HA mutations and with other viral proteins (e.g., neuraminidase) are poorly captured by current models [54].

Future advances will likely involve multi-modal models that jointly process sequence, structure, and glycan shield information [55]. Integration with real-time genomic surveillance platforms, such as those described in Nanopore Sequencing for Real-Time Genomic Surveillance of Avian Influenza Viruses in Poultry, could enable near-real-time drift forecasting [56]. Additionally, reinforcement learning approaches may optimize vaccine strain selection by simulating the co-evolutionary dynamics between virus and host immunity [57].

Conclusion

Machine learning has become an indispensable tool for predicting antigenic drift in influenza hemagglutinin, enabling proactive vaccine strain selection and enhancing pandemic preparedness in veterinary settings. By combining sequence surveillance, structural modeling, and functional data, these computational methods provide a quantitative framework for understanding and anticipating HA evolution. Continued development of robust, generalizable models will further strengthen global influenza surveillance networks.

References

[1] Murphy FA, Gibbs EPJ, Horzinek MC, Studdert MJ. Veterinary Virology. 3rd ed. Academic Press; 1999.

[2] Swayne DE, Glisson JR, McDougald LR, Nolan LK, Suarez DL, Nair VL, editors. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020.

[3] Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56(1):152-179.

[4] Knipe DM, Howley PM, editors. Fields Virology. 6th ed. Lippincott Williams & Wilkins; 2013.

[5] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 12th ed. WOAH; 2023.

[6] Goodfellow I, Bengio Y, Courville A. Deep Learning. MIT Press; 2016.

[7] Fowler DM, Fields S. Deep mutational scanning: a new style of protein science. Nat Methods. 2014;11(8):801-807.

[8] Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531-569.

[9] Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem. 2010;285(37):28403-28409.

[10] Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289(5796):373-378.

[11] Kaverin NV, Rudneva IA, Ilyushina NA, et al. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol. 2002;83(Pt 10):2497-2505.

[12] Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371-376.

[13] Lee PS, Wilson IA. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol. 2015;386:323-341.

[14] Wu NC, Wilson IA. A perspective on the structural and functional constraints of influenza A virus hemagglutinin. Curr Opin Virol. 2020;41:43-51.

[15] Krammer F, Palese P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol. 2013;3(5):521-530.

[16] Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci USA. 1993;90(9):4171-4175.

[17] Hensley SE, Das SR, Bailey AL, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science. 2009;326(5953):734-736.

[18] Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999;286(5446):1921-1925.

[19] Lapedes A, Farber R. The geometry of shape space: application to influenza. J Theor Biol. 2001;212(1):57-69.

[20] Neher RA, Bedford T, Daniels RS, Russell CA, Shraiman BI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proc Natl Acad Sci USA. 2016;113(12):E1701-E1709.

[21] Łuksza M, Lässig M. A predictive fitness model for influenza. Nature. 2014;507(7490):57-61.

[22] Du X, Dong L, Lan Y, et al. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun. 2012;3:709.

[23] Lee AJ, Das SR, Wang W, et al. Diversifying selection analysis predicts antigenic evolution of 2009 pandemic H1N1 influenza A virus in humans. J Virol. 2015;89(10):5427-5440.

[24] Yin R, Tran VH, Zhou X, Zheng J, Kwoh CK. Predicting antigenic variants of influenza A/H3N2 viruses using random forest and convolutional neural network. Sci Rep. 2019;9(1):14260.

[25] Zhou X, Yin R, Kwoh CK, Zheng J. A context-free encoding scheme for protein sequences for deep learning-based antigenic variant prediction. Bioinformatics. 2020;36(12):3792-3799.

[26] AlQuraishi M. End-to-end differentiable learning of protein structure. Cell Syst. 2019;8(4):292-301.

[27] Rives A, Meier J, Sercu T, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc Natl Acad Sci USA. 2021;118(15):e2016239118.

[28] Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235-242.

[29] Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res. 2009;19(2):271-273.

[30] Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589.

[31] Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002;9(9):646-652.

[32] Amaro RE, Mulholland AJ. Multiscale methods in drug design bridge chemical and biological complexity. Nat Rev Chem. 2018;2(4):0148.

[33] Tunyasuvunakool K, Adler J, Wu Z, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596(7873):590-596.

[34] Doud MB, Bloom JD. Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin. Viruses. 2016;8(6):155.

[35] Haddox HK, Dingens AS, Bloom JD. Experimental estimation of the effects of all amino-acid mutations to HIV's envelope protein on viral replication in cell culture. PLoS Pathog. 2016;12(12):e1006114.

[36] Wu NC, Olson CA, Du Y, et al. Functional constraint profiling of a viral protein reveals discordance of evolutionary conservation and functionality. PLoS Genet. 2015;11(7):e1005310.

[37] Sinai S, Kelsic E, Church GM, Nowak MA. Variational auto-encoding of protein sequences. arXiv:1712.03346. 2017.

[38] Biswas S, Khimulya G, Alley EC, Esvelt KM, Church GM. Low-N protein engineering with data-efficient deep learning. Nat Methods. 2021;18(4):389-396.

[39] Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494.

[40] World Organisation for Animal Health (WOAH). Avian influenza portal. Accessed 2025.

[41] Russell CA, Jones TC, Barr IG, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320(5874):340-346.

[42] Bedford T, Suchard MA, Lemey P, et al. Integrating influenza antigenic dynamics with molecular evolution. eLife. 2014;3:e01914.

[43] Dingens AS, Haddox HK, Overbaugh J, Bloom JD. Comprehensive mapping of HIV-1 escape from a broadly neutralizing antibody. Cell Host Microbe. 2017;21(6):777-787.

[44] Swayne DE, Kapczynski DR. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev. 2008;225:314-331.

[45] Anderson TK, Chang J, Arendsee ZW, et al. Swine influenza A viruses and the tangled relationship with humans. Cold Spring Harb Perspect Med. 2021;11(3):a038737.

[46] Lewis NS, Russell CA, Langat P, et al. The global antigenic diversity of swine influenza A viruses. eLife. 2016;5:e12217.

[47] Peiris JSM, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev. 2007;20(2):243-267.

[48] Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19(7):409-424.

[49] Shi J, Deng G, Ma S, et al. Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017. Cell Host Microbe. 2018;24(4):558-568.

[50] Huddleston J, Barnes JR, Rowe T, et al. Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife. 2020;9:e60067.

[51] Gal Y, Ghahramani Z. Dropout as a Bayesian approximation: representing model uncertainty in deep learning. Proc Int Conf Mach Learn. 2016;48:1050-1059.

[52] Vijaykrishna D, Mukerji R, Smith GJ. RNA virus reassortment: an evolutionary mechanism for host jumps and immune evasion. PLoS Pathog. 2015;11(7):e1004902.

[53] Anderson TK, Campbell BA, Nelson MI, et al. Characterization of co-circulating swine influenza A viruses in North America and the identification of a novel H1 genetic clade with antigenic significance. Virus Res. 2013;178(2):177-186.

[54] Gong LI, Suchard MA, Bloom JD. Stability-mediated epistasis constrains the evolution of an influenza protein. eLife. 2013;2:e00631.

[55] Senior AW, Evans R, Jumper J, et al. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706-710.

[56] Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228-232.

[57] Silver D, Schrittwieser J, Simonyan K, et al. Mastering the game of Go without human knowledge. Nature. 2017;550(7676):354-359. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.